2-47512435-C-G

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2

The NM_022055.2(KCNK12):​c.*8472G>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000578 in 1,599,998 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.0028 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00034 ( 3 hom. )

Consequence

KCNK12
NM_022055.2 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.826

Publications

1 publications found
Variant links:
Genes affected
KCNK12 (HGNC:6274): (potassium two pore domain channel subfamily K member 12) This gene encodes one of the members of the superfamily of potassium channel proteins containing two pore-forming P domains. The product of this gene has not been shown to be a functional channel, however, it may require other non-pore-forming proteins for activity. [provided by RefSeq, Jul 2008]
MSH2 (HGNC:7325): (mutS homolog 2) This locus is frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). When cloned, it was discovered to be a human homolog of the E. coli mismatch repair gene mutS, consistent with the characteristic alterations in microsatellite sequences (RER+ phenotype) found in HNPCC. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]
MSH2 Gene-Disease associations (from GenCC):
  • Lynch syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, G2P
  • Lynch syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Muir-Torre syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, G2P
  • mismatch repair cancer syndrome 1
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • mismatch repair cancer syndrome 2
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • ovarian cancer
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • malignant pancreatic neoplasm
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • prostate cancer
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • rhabdomyosarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • breast cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 2-47512435-C-G is Benign according to our data. Variant chr2-47512435-C-G is described in ClinVar as Benign. ClinVar VariationId is 926048.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 433 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_022055.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNK12
NM_022055.2
MANE Select
c.*8472G>C
3_prime_UTR
Exon 2 of 2NP_071338.1Q9HB15
MSH2
NM_001406638.1
c.*156C>G
3_prime_UTR
Exon 18 of 18NP_001393567.1
MSH2
NM_001406641.1
c.*156C>G
3_prime_UTR
Exon 17 of 17NP_001393570.1P43246-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNK12
ENST00000327876.5
TSL:1 MANE Select
c.*8472G>C
3_prime_UTR
Exon 2 of 2ENSP00000327611.3Q9HB15
MSH2
ENST00000406134.5
TSL:1
c.*1C>G
3_prime_UTR
Exon 16 of 16ENSP00000384199.1E9PHA6
MSH2
ENST00000910408.1
c.*156C>G
3_prime_UTR
Exon 17 of 17ENSP00000580467.1

Frequencies

GnomAD3 genomes
AF:
0.00284
AC:
432
AN:
152190
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00982
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000982
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00384
GnomAD2 exomes
AF:
0.000641
AC:
143
AN:
223112
AF XY:
0.000492
show subpopulations
Gnomad AFR exome
AF:
0.00913
Gnomad AMR exome
AF:
0.000351
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000908
Gnomad OTH exome
AF:
0.000179
GnomAD4 exome
AF:
0.000339
AC:
491
AN:
1447690
Hom.:
3
Cov.:
31
AF XY:
0.000295
AC XY:
212
AN XY:
718698
show subpopulations
African (AFR)
AF:
0.0116
AC:
384
AN:
33092
American (AMR)
AF:
0.000426
AC:
18
AN:
42270
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25802
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39450
South Asian (SAS)
AF:
0.0000718
AC:
6
AN:
83538
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51852
Middle Eastern (MID)
AF:
0.000524
AC:
3
AN:
5730
European-Non Finnish (NFE)
AF:
0.0000235
AC:
26
AN:
1106040
Other (OTH)
AF:
0.000901
AC:
54
AN:
59916
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.447
Heterozygous variant carriers
0
21
42
63
84
105
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00284
AC:
433
AN:
152308
Hom.:
0
Cov.:
32
AF XY:
0.00262
AC XY:
195
AN XY:
74488
show subpopulations
African (AFR)
AF:
0.00982
AC:
408
AN:
41560
American (AMR)
AF:
0.000981
AC:
15
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68034
Other (OTH)
AF:
0.00380
AC:
8
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
22
44
65
87
109
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000804
Hom.:
0
Bravo
AF:
0.00308
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Hereditary cancer-predisposing syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.61
DANN
Benign
0.59
PhyloP100
-0.83
Mutation Taster
=100/0
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs114545543; hg19: chr2-47739574; API